|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/216 | |
| A61K 31/185 | |||
| A61K 31/192 | |||
| A61P 1/16 | |||
| A61P 13/12 | |||
| A61P 43/00 | |||
| G01N 33/68 |
| (11) | Patento numeris | 3222275 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17154858.9 |
| Europos patento paraiškos padavimo data | 2012-09-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-09-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261636256 P | 2012-04-20 | US |
| (72) |
SCHARSCHMIDT, Bruce, US
MOKHTARANI, Masoud, US
|
| (73) |
Immedica Pharma AB,
Norrtullsgatan 15, 113 29 Stockholm,
SE
|
| (54) | METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS |
| METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS |